Tag: insulin efsitora alfa

Dual VA and Medicare coverage linked to glucose strip overuse

Weekly insulin efsitora alfa is non-inferior to daily insulin degludec for reducing HbA1c in type 1 diabetes

byNeel Mistryand1 others

October 9, 2024

1. Once weekly efsitora demonstrated non-inferiority compared with degludec with regards to change in HbA1c. 2. Patients in the efsitora ...

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

Nirsevimab (Beyfortus) may reduce severe respiratory syncytial virus infections among infants
An artificial intelligence (AI) tool achieved high diagnostic accuracy for the identification and prediction of sepsis
Use of long-acting broadly neutralizing antibodies may delay human immunodeficiency virus (HIV) rebound following discontinuation of antiretroviral therapy

No Result

View All Result

Tag: insulin efsitora alfa

Weekly insulin efsitora alfa is non-inferior to daily insulin degludec for reducing HbA1c in type 1 diabetes

2MM+ All Access

Recent Reports

The medical literature, distilled daily.

Membership benefits